About us
Our Vision
Worldwide, 1 in 3 people are affected by neurological disorders such as Alzheimer’s, stroke, epilepsy, depression, and ADHD. According to the WHO, neurological disorders pose one of the greatest threats to public health, underscoring the need for more tailored treatments and advanced tools for early diagnosis.
Fortunately, Science has a solution to it: biomarkers. However, existing tools like fMRI and EEG are often unsuitable because they are either too expensive, inaccessible, or lack sufficient accuracy.
At optohive, we are committed to changing this. Our next-generation, wearable brain imaging technology offers a powerful tool for clinicians and researchers working to unlock deeper insights into brain function. By providing real-time, non-invasive brain monitoring, optohive enables more efficient and cost-effective research, accelerates clinical trials, and supports earlier diagnosis and better treatment outcomes for patients with neurological disorders.
With precision brain imaging at your fingertips, we are helping to advance the global effort to combat neurological diseases and improve the quality of life for millions worldwide.
Meet Our Dedicated Team
Our team at Optohive is composed of experts in neuroscience, commercialisation and technology, all committed to advancing brain imaging technology. Get to know the people who are driving innovation and excellence in our field.

Dr. Dominik Wyser
Chief Executive Officer

Michael Wyser
Chief Operating Officer

Dr. Matteo Pavan
Head of Hardware Engineering & Technology

Marc Willhaus
Head of Software Development

Bianca Badii
Product Manager

Dr. Josef Schönhammer
Neuroscientist
Neuroscientists

Camille Pescatore
Neuroscientist

Cléo Perrin
Neuroscientist
Advisory Board

Prof. Roger Gassert
Neurotechnology

Prof. Martin Wolf
Brain Imaging

Prof. Oliver Lambercy
Rehabilitation Engineering

Dr. med. Meret Branscheidt
Stroke Expert